RxDoctor Payments Data

Haley Maxon

Family · Higginsville, MONPI 1578955159

Payments from drug & device makers

$3,035in general payments, 2019–2025

Across 185 payments — averaging $16.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$638
  • AstraZeneca$419
  • Lilly USA, LLC$403
  • Novo Nordisk$280
  • Merck$163
  • Amgen$147
  • plus $984 from 21 others

What the payments were for

  • Food & beverage$3,035100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,035 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide49$44,363
JardianceEmpagliflozin26$31,073
JanuviaSitagliptin Phosphate38$28,152
XareltoRivaroxaban24$21,268
EliquisApixaban18$17,760
FarxigaDapagliflozin Propanediol15$10,951
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$9,828
Fiasp FlextouchInsulin Aspart (Niacinamide)11$9,451
Bydureon BciseExenatide Microspheres12$9,410
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog18$8,465
Repatha SureclickEvolocumab13$7,500
Repatha SyringeEvolocumab12$6,609
Lantus SolostarInsulin Glargine,hum.Rec.Anlog48$6,367
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$5,543
Humalog Kwikpen U-100Insulin Lispro25$5,202

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$280$44,36349 claims
Boehringer IngelheimJardiance$29$31,07326 claims
MerckJanuvia$163$28,15238 claims
PfizerEliquis, Dilantin$130$19,63430 claims
AstraZenecaFarxiga, Symbicort$419$13,55026 claims
AbbVieSynthroid$638$1,84920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,812 family providers in Missouri.

Other family in Higginsville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →